Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 50 of 100
Health
FDA Approves New Migraine Drug: What You Need to Know
By
Don Reisinger
May 18, 2018
Health
The FDA Approved a Promising New Drug to Treat Migraines. Now, the Drugmakers’ Stock Prices Are Rising
By
David Meyer
May 18, 2018
Health
The FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By
Sy Mukherjee
May 17, 2018
Health
An All-Star Panel Tackles Trump’s Drug Price Plan, Innovation in Health Care—And More
By
Sy Mukherjee
May 16, 2018
Health
We Don’t Have a Cure for the Common Cold. But This New Treatment Might Stop It in Its Tracks
By
Sy Mukherjee
May 14, 2018
Health
Why Trump’s Big Drug Price Speech Sent Health Care Stocks Soaring
By
Sy Mukherjee
May 11, 2018
Health
Takeda Finally Inks a Deal to Buy Shire in One of the Biggest Pharma Takeovers Ever
By
David Meyer
May 8, 2018
Health
A $14,000 Cholesterol Drug Is Getting A 69% Price Cut
By
Kirsten Korosec
May 1, 2018
Health
Why Pfizer and Merck Stock Both Slumped After Their Earnings Reports
By
Sy Mukherjee
May 1, 2018
Health
How High Drug Prices and Big Lobbying Budgets Go Together for Big Pharma
By
Elizabeth Lucas
,
Jay Hancock, Kaiser Health News
and
Anne VanderMey
April 26, 2018
Health
Epilepsy Drug Made From Marijuana Plant Gets Backing From FDA Staff
By
Bloomberg
and
Wilder Davies
April 17, 2018
Health
Merck’s Bet on Cancer Immunotherapy Is Paying Off in Spades and Helping Lung Cancer Patients Live Longer
By
Sy Mukherjee
April 16, 2018
Health
Hepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300
By
Sy Mukherjee
April 12, 2018
Health
Researchers Just Proposed a Radical New Way of Defining Alzheimer’s. Could It Lead to Better Drugs?
By
Sy Mukherjee
April 10, 2018
Health
This Lung Cancer Drug Could Let Patients Forgo Chemo—And It’s Sending Merck’s Stock Soaring
By
Sy Mukherjee
April 9, 2018
Most Popular
Commentary
Ray Dalio: I've studied 500 years of history and fear we're entering the most dangerous phase of the 'Big Cycle'
By
Ray Dalio
Success
When Jamie Dimon was fired from Citigroup, his daughters asked: 'Will we be homeless? Can I still go to college? Can I...
By
Eleanor Pringle
Middle East
Trump's AI czar calls for U.S. to 'get out' of war and warns Iran has a 'dead man's switch' that could render Gulf...
By
Jason Ma